Project Details
Description
A Phase 2, Single-Arm, Open-Label Extension Study, Evaluating the Long-Term Safety and Clinical Efficacy of INBRX-101 in Adults with Alpha-1 Antitrypsin Deficiency (AATD) Emphysema
| Status | Active |
|---|---|
| Effective start/end date | 5/1/24 → 5/31/28 |
Funding
- INHIBRX, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.